To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT06158750
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT06158750
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06158750. Allocation not applicable; no masking; primary purpose treatment. Start 2023-11-17 (actual); primary completion 2026-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
- Condition
- Intracranial Aneurysm
- Intervention (Device)
- p64/p48 MW HPC Flow Modulation Device
- Lead sponsor
- Shanghai Wallaby Medical Technologies Co.,Inc.
- Collaborator
- Phenox GmbH
- Collaborator
- Beijing Wallaby Medical Technologies Co.,Inc.
Record details
- Record id
cardio:ct-nct06158750- Content hash
761b5a35dff384bf16f46267b8e5bb1237aeff3bb6573cd6ff387d41bb974c6f